WS

William L. Smith

VI Vivus: 8 patents #6 of 25Top 25%
AI A. H. Robins Company, Incorporated: 5 patents #13 of 80Top 20%
S( Syntex (U.S.A.): 3 patents #196 of 599Top 35%
WU Washington University: 2 patents #386 of 1,596Top 25%
BS Bristol-Myers Squibb: 2 patents #1,811 of 3,969Top 50%
Overall (All Time): #252,074 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11813308 Treatment of cardiovascular disease using ActRII ligand traps Keith Hruska, Yifu Fang, Nianhang Chen 2023-11-14
10195249 Activin-ActRII antagonists and uses for treating bone and other disorders Victoria Sung, Randall Stevens, Victor Schorr Sloan, Keith Hruska, Yifu Fang 2019-02-05
6548490 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2003-04-15
6403597 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation Leland F. Wilson, Paul C. Doherty, Jr., Virgil A. Place, Ibrahim AbouBakr Abdel-Hamid Abdou Ali 2002-06-11
6228864 Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation Paul C. Doherty, Jr., Virgil A. Place 2001-05-08
6156753 Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2000-12-05
6127363 Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2000-10-03
6037346 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction Paul C. Doherty, Jr., Virgil A. Place 2000-03-14
6037360 Administration of 5-HT.sub.3 receptor antagonists to treat premature ejaculation Paul C. Doherty, Jr., Virgil A. Place 2000-03-14
5922341 Local administration of pharmacologically active agents to treat premature ejaculation Virgil A. Place 1999-07-13
5202318 Tricyclic compounds acting at serotonin receptor subtypes Jacob Berger, Robin Clark, Richard Eglen, Klaus Weinhardt 1993-04-13
5202333 Tricyclic 5-HT.sub.3 receptor antagonists Jacob Berger, Robin Clark, Richard Eglen, Klaus Weinhardt 1993-04-13
5192770 Serotonergic alpha-oxoacetamides Robin Clark, Richard Eglen, Joseph M. Muchowski, Klaus Weinhardt 1993-03-09
4863919 Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes 1989-09-05
4857553 Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents John Ward 1989-08-15
4722834 Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs Lina C. Teng, Stephen C. Bearekman, Lennox B. Turnbull, Reevis S. Alphin 1988-02-02
4717563 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs Reevis S. Alphin, Harry R. Munson, Jr., Robert F. Boswell, Jr. 1988-01-05
4547514 Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity Pershottam P. Mathur 1985-10-15